Mirae Asset MF Sells 57,842 Gland Pharma Shares, Stake Down to 2.95%

Mirae Asset Mutual Fund has reported the sale of 57,842 equity shares of Gland Pharma Ltd. The transaction, executed via open market on September 28, 2026, reduced Mirae Asset's shareholding in the company. Prior to this sale, Mirae Asset held 4,930,033 shares, representing 2.99% of Gland Pharma's total voting capital. Following the sale, their holding decreased to 4,872,191 shares, which constitutes 2.95% of the total voting capital. The sale amounted to a 0.04% reduction in their stake.